Olmesartan Medoxomil (Page 5 of 5)
17 PATIENT COUNSELING INFORMATION
Pregnancy: Advise female patients of childbearing age about the consequences of exposure to olmesartan medoxomil tablets during pregnancy. Discuss treatment options with women planning to become pregnant. Tell patients to report pregnancies to their physicians as soon as possible [see Warnings and Precautions (5.1) and Use in Specific Populations (8.1)].
Lactation: Advise nursing women not to breastfeed during treatment with olmesartan medoxomil tablets [see Use in Specific Populations (8.2)].
Hyperkalemia: Advise patients not to use potassium supplements or salt substitutes that contain potassium without consulting their healthcare provider [see Drug Interactions (7.1)].
Manufactured by:
Alkem Laboratories Ltd.
Mumbai — 400 013, INDIA
Distributed by:
Ascend Laboratories, LLC
Parsippany, NJ 07054
Relabeled by:
Proficient RX LP
Thousand Oaks, CA 91320
Revised: December, 2019
Rx Only
PT 2245-02
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Rx only
NDC 71205-458-30
Olmesartan Medoxomil Tablets 20 mg 30 Tablets
Rx only
NDC 71205-459-30
Olmesartan Medoxomil Tablets 40 mg 30 Tablets
OLMESARTAN MEDOXOMIL olmesartan medoxomil tablet, coated | ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
|
OLMESARTAN MEDOXOMIL olmesartan medoxomil tablet, coated | ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
|
Labeler — Proficient Rx LP (079196022) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Proficient Rx LP | 079196022 | REPACK (71205-458), RELABEL (71205-458), REPACK (71205-459), RELABEL (71205-459) |
Revised: 06/2020 Proficient Rx LP
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.
https://medlibrary.org/lib/rx/meds/olmesartan-medoxomil-1/page/5/